Home › Ductal Carcinoma In Situ (DCIS)
Ductal Carcinoma In Situ (DCIS) clinical trials recruiting in the U.S.
30 studies for Ductal Carcinoma In Situ (DCIS) are recruiting participants at sites across the United States.
Cities with the most studies
- Houston, TX5 studies
- New York City, NY5 studies
- Columbus, OH4 studies
- Chicago, IL4 studies
- Tampa, FL3 studies
- Philadelphia, PA3 studies
- Kansas City, KS3 studies
By state
- California7 studies
- Florida7 studies
- Illinois5 studies
- Kansas3 studies
- Michigan4 studies
- New York6 studies
- Ohio5 studies
- Oregon3 studies
- Pennsylvania4 studies
- Texas5 studies
Recently updated studies
DCIS: RECAST Trial Ductal Carcinoma In Situ: Re-Evaluating Conditions for Active Surveillance Suitability as Treatment
RecruitingPhase 2
Ages 18 and older · Women · Updated Sep 28, 2026 · NCT06075953CAN1012 in Pre-Malignant DCIS and LCIS
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 24, 2026 · NCT07408856Personalized Prone Immobilization for Accelerated Partial Breast Radiotherapy
Recruiting
Ages 40 and older · Women · Updated Sep 23, 2026 · NCT07711847Women Informed to Screen Depending on Measures of Risk (Wisdom Study)
RecruitingHealthy volunteers welcome
Ages 30 to 74 · Women · Updated Sep 21, 2026 · NCT02620852Study of 3-Day Partial Breast Radiation Therapy in Women With Breast Cancer
RecruitingPhase 2
Ages 45 and older · Women · Updated Sep 21, 2026 · NCT04084730Novel Cavity Marking Technique in Breast Cancer Patients Undergoing Breast Conservation Surgery With Oncoplastic Reconstruction for the Delivery of Adjuvant Radiotherapy and Accuracy of Recommended Re-excisions
Recruiting
Ages 18 and older · All sexes · Updated Sep 9, 2026 · NCT06903468Ultra Hypo-fractionated Adjuvant Whole Breast Radiation Therapy With Simultaneous Integrated Boost for Early-Stage Breast Cancer (H-ASSIST)
RecruitingPhase 2
Ages 50 and older · Women · Updated Sep 3, 2026 · NCT06902311Prototype DAA/TAA Vaccine Targeting MUC1 for Immune Interception and Prevention in Ductal Carcinoma In Situ
RecruitingPhase 1
Ages 18 and older · Women · Updated Aug 18, 2026 · NCT06218303Low Dose Tamoxifen With or Without Omega-3 Fatty Acids for Breast Cancer Risk Reduction
RecruitingPhase 2Healthy volunteers welcome
Ages 45 to 74 · Women · Updated Aug 4, 2026 · NCT06195306Finding the Best Tamoxifen Dose for Breast Cancer Risk Reduction in Premenopausal Women, RENAISSANCE Trial
RecruitingPhase 2
Ages 18 to 55 · Women · Updated Jul 27, 2026 · NCT06184750Identifying and Caring for Individuals With Inherited Cancer Syndrome
RecruitingHealthy volunteers welcome
Ages 18 and older · All sexes · Updated Jul 14, 2026 · NCT04494945Acolbifene Versus Low Dose Tamoxifen for the Prevention of Breast Cancer in Premenopausal Women at High Risk for Development of Breast Cancer
RecruitingPhase 2
Ages 35 and older · Women · Updated Jul 7, 2026 · NCT05941520Impact of Dietary Inflammatory Potential on Breast Cancer Risk
RecruitingObservational study
Ages 18 and older · All sexes · Updated Jun 12, 2026 · NCT05178498Real-Time MRI-Guided 3-Fraction Accelerated Partial Breast Irradiation in Early Breast Cancer
RecruitingPhase 2
Ages 40 and older · Women · Updated Jun 11, 2026 · NCT03936478Impact of COVID-19 Pandemic on Out-of-Pocket Costs, Lost Wages, and Unemployment in Patients With Breast Cancer Undergoing Breast Surgery
RecruitingObservational study
Ages 18 and older · Women · Updated May 4, 2026 · NCT04169542The PREDICT Registry:
RecruitingObservational study
Ages 30 to 85 · Women · Updated Apr 17, 2026 · NCT03448926Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer
Recruiting
Ages 18 and older · Women · Updated Apr 16, 2026 · NCT02918474EXploring Inflammation and Social deTerminants Study in Breast Cancer Patients
RecruitingObservational study
Ages 18 and older · Women · Updated Mar 17, 2026 · NCT07478016Surgical Excision vs Neoadjuvant Radiotherapy+Delayed Surgical Excision of Ductal Carcinoma
Recruiting
Ages 18 and older · Women · Updated Mar 12, 2026 · NCT03909282A Vaccine (H2NVAC) Before Surgery for the Treatment of HER2-Expressing Ductal Carcinoma In Situ
RecruitingPhase 1
Ages 18 and older · Women · Updated Mar 5, 2026 · NCT04144023A Patient Navigation Program for Addressing Disparities in Breast Cancer Care
Recruiting
Ages 18 and older · Women · Updated Feb 17, 2026 · NCT06350500Pre-operative SABR With and Without Caloric Restriction for Early Stage Breast Cancer
Recruiting
Ages 40 and older · All sexes · Updated Jan 23, 2026 · NCT049594745 vs. 9-day Course of Whole Breast Radiotherapy With Boost for Early-stage Breast Cancer
RecruitingPhase 2
Ages 18 and older · Women · Updated Dec 9, 2025 · NCT06961955ASHBY: Accelerated Super-Hypofractionated Breast Brachytherapy
RecruitingPhase 2
Ages 45 to 79 · Women · Updated Nov 21, 2025 · NCT06185205A Study of Disappearing Markers for Daily Radiation Treatment Delivery for Breast Cancer Patients.
Recruiting
Ages 18 and older · Women · Updated Sep 18, 2025 · NCT07095114From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.